Validation of the fatigue severity scale in a Swiss cohort.
- Valko PO Department of Neurology, University Hospital of Zurich, Zurich, Switzerland.
- Bassetti CL
- Bloch KE
- Held U
- Baumann CR
- 2008-11-19
Published in:
- Sleep. - 2008
Adolescent
Adult
Aged
Aged, 80 and over
Cohort Studies
Disorders of Excessive Somnolence
Fatigue
Female
Humans
Male
Middle Aged
Multiple Sclerosis
Myocardial Ischemia
Prevalence
Quality of Life
Severity of Illness Index
Sleep Disorders, Circadian Rhythm
Surveys and Questionnaires
Switzerland
Young Adult
English
BACKGROUND
Fatigue is highly prevalent and has a negative impact on quality of life and performance in a variety of disorders. The 9-item Fatigue Severity Scale (FSS) is one of the most commonly used self-report questionnaires to measure fatigue, but has only been validated in small sample-sized studies and in single disorders.
OBJECTIVE
To validate the FSS in healthy subjects and different disorders known to be commonly associated with fatigue.
MATERIAL AND METHODS
The FSS was administered to 454 healthy subjects, 188 patients with multiple sclerosis (MS), 235 patients with recent ischemic stroke, and 429 patients with sleep-wake disorders including narcolepsy with cataplexy (n=22), restless legs syndrome (RLS) (n=79), sleep apnea (n=108), insomnia (n=62), parasomnia (n=25), excessive daytime sleepiness/hypersomnia of other origin (n=84, and other sleep-wake disorders (n=49.
RESULTS
FSS scores were 4.66 +/- 1.64 (mean +/- SD) in patients with MS, 3.90 +/- 1.85 in patients after ischemic stroke, and 4.34 +/- 1.64 in patients with sleep-wake disorders. Compared to patients, values were significantly lower in healthy subjects (3.00 +/- 1.08, P < 0.01). Scores did not correlate with gender, age, or education. Item analysis showed an excellent internal consistency and reliability (Cronbach alpha = 0.93). Test-retest variability was assessed in 104 healthy subjects, showing stable values over time (2.94 +/- 0.90 vs. 2.90 +/- 0.74; P = 0.27).
CONCLUSIONS
This first validation of a fatigue scale in a large sample size demonstrates that the FSS is a simple and reliable instrument to assess and quantify fatigue for clinical and research purposes.
Fatigue is highly prevalent and has a negative impact on quality of life and performance in a variety of disorders. The 9-item Fatigue Severity Scale (FSS) is one of the most commonly used self-report questionnaires to measure fatigue, but has only been validated in small sample-sized studies and in single disorders.
OBJECTIVE
To validate the FSS in healthy subjects and different disorders known to be commonly associated with fatigue.
MATERIAL AND METHODS
The FSS was administered to 454 healthy subjects, 188 patients with multiple sclerosis (MS), 235 patients with recent ischemic stroke, and 429 patients with sleep-wake disorders including narcolepsy with cataplexy (n=22), restless legs syndrome (RLS) (n=79), sleep apnea (n=108), insomnia (n=62), parasomnia (n=25), excessive daytime sleepiness/hypersomnia of other origin (n=84, and other sleep-wake disorders (n=49.
RESULTS
FSS scores were 4.66 +/- 1.64 (mean +/- SD) in patients with MS, 3.90 +/- 1.85 in patients after ischemic stroke, and 4.34 +/- 1.64 in patients with sleep-wake disorders. Compared to patients, values were significantly lower in healthy subjects (3.00 +/- 1.08, P < 0.01). Scores did not correlate with gender, age, or education. Item analysis showed an excellent internal consistency and reliability (Cronbach alpha = 0.93). Test-retest variability was assessed in 104 healthy subjects, showing stable values over time (2.94 +/- 0.90 vs. 2.90 +/- 0.74; P = 0.27).
CONCLUSIONS
This first validation of a fatigue scale in a large sample size demonstrates that the FSS is a simple and reliable instrument to assess and quantify fatigue for clinical and research purposes.
- Language
-
- English
- Open access status
- green
- Identifiers
-
- DOI 10.1093/sleep/31.11.1601
- PMID 19014080
- Persistent URL
- https://folia.unifr.ch/global/documents/4464
Statistics
Document views: 14
File downloads:
- fulltext.pdf: 0